References
- Brown Z, Dudley M, Habif T, et al. Audio forum on herpes simplex virus: patient counseling. Scientific Exchange Inc, Nov 1996
- Brown Z, Patel R, Reitano M, et al. Herpesvirus infections: treatment options in the new millennium. A symposium report. World Health CME, World Health Communications, Inc, Denver, April 29, 1996
- Brown Z, Dudley M, Habif T, et al. Audio forum on herpes simplex virus: suppressive therapy. Scientific Exchange Inc, Sep 1996
- Fleming D, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337(16): 1105–11
- Habif T. The diagnostic manual of herpesvirus infections. Research Triangle Park, NC: Burroughs Wellcome Co, 1995
- Fitzpatrick TB, et al. Dermatology in general medicine. 4th ed. New York: McGraw-Hill, 1993: 2531–47
- Spruance SL, Rea TL, Thoming C, et al. Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA 1997; 277(17): 1373–9
- Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group. Genitourin Med 1997; 73(2): 110–6
- Habif TB. Clinical dermatology. 3d ed. Mosby-Year Book, 1996: 306–13, 337–44
- Goldberg LH, Kaufman R, Kurtz TO, et al. Long-term suppression of recurrent genital herpes with acyclovir: a 5-year benchmark acyclovir study group. Arch Dermatol 1993; 129(5): 582–7
- McCrary ML, Memar OM, Herne KB, et al. Drugs with antiviral activity used in clinical dermatology. Fitzpatrick's J Clin Dermatol 1995; 3(6): 44–51
- Drugs for non-HIV viral infections. Med Lett Drug Ther 1997; 39(1006): 69–76
- Wald A. Beyond efficacy: new issues for HSV antiviral therapy. Genitourin Med 1997; 73(2):83–4
- PCS Rx Review. New trends in prescription therapies, benefits, costs: current antiviral therapies for herpes virus. Scotts-dale, AZ: PCS Health Systems, Spring 1997
- Valtrex caplets: occurrence of thrombotic microangiopathy (TMA) in severely immunocompromised patients [physician handout]. Research Triangle Park, NC: Glaxo Wellcome, 1996
- Valtrex caplets: use for the suppression of recurrent genital herpes infections [physician handout]. Research Triangle Park, NC: Glaxo Wellcome, 1996
- Topical penciclovir for herpes labialis. Med Lett Drug Ther 1997; 39(1003): 57–9
- Selected readings
- Elliot WT, Chan J. Penciclovir cream for treatment of cold sores. Intern Med Alert 1997; 19(10): 78–9
- Foreman KE, Friborg J Jr, Kong WP, et al. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med 1997; 336(3): 163–71
- Patel R, Bodsworth NJ, Woolley P, et al. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. Genitourin Med 1997; 73(2): 105–9
- Spruance SL, Tyring SK, DeGregorio B, et al. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 1996; 156(15): 1729–35
- Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333(12): 770–5